Beauty Health Co SKIN.OQ SKIN.O is expected to show a fall in quarterly revenue when it reports results on November 6 for the period ending September 30 2025
The Long Beach California-based company is expected to report a 13.0% decrease in revenue to $68.592 million from $78.8 million a year ago, according to the mean estimate from 9 analysts, based on LSEG data.
LSEG's mean analyst estimate for Beauty Health Co is for a loss of 7 cents per share.
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 6 "hold" and 2 "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Beauty Health Co is $2.00, about 31.5% above its last closing price of $1.37
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Jun. 30 2025 | -0.05 | -0.05 | 0.03 | Beat | 156.8 |
Mar. 31 2025 | -0.13 | -0.13 | -0.08 | Beat | 36.6 |
Dec. 31 2024 | -0.11 | -0.11 | -0.08 | Beat | 25.6 |
Sep. 30 2024 | -0.12 | -0.11 | -0.09 | Beat | 19.2 |
Jun. 30 2024 | -0.03 | -0.05 | 0.00 | Beat | 102 |
Mar. 31 2024 | -0.13 | -0.14 | -0.01 | Beat | 92.7 |
Dec. 31 2023 | -0.08 | -0.08 | -0.07 | Beat | 7.4 |
Sep. 30 2023 | 0.09 | 0.09 | 0.10 | Beat | 17.6 |
This summary was machine generated November 4 at 21:39 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Comments